We in-license, register, and distribute novel healthcare products for international manufacturers — with the regulatory rigour and retail reach Canadian consumers expect.
You've built something exceptional. We get it on Canadian shelves — through the right channels, at the right price, with full regulatory and marketing support.
Volo operates an established Canadian distribution platform with proven retail relationships, a growing in‑licensed pipeline, and a leadership team that has done this before.
Heme iron oral supplement. For the prevention of iron deficiency and iron deficiency anemia. OptiFer is designed for individuals who require effective iron replenishment — particularly women of reproductive age, pregnant women, and patients who have not tolerated conventional non-heme iron supplementation. The product addresses a high-prevalence clinical gap in Women’s Health and Hematology, where […]
Femistina Plus provides round-the-clock defense against recurrent UTIs with its innovative triple-action mechanism. Femistina Plus is designed for use in women with a history of recurrent cystitis who are seeking a structured, non-antibiotic prophylactic strategy. It is positioned as a clinically credible adjunct or alternative to continuous low-dose antibiotic prophylaxis, aligned with global antibiotic stewardship […]
ProZema reduces the symptoms of eczema and atopic dermatitis. Features a unique blend of 3 patented probiotic strains
A disciplined, capital‑efficient platform with proven retail relationships, an experienced operating team, and an expanding pipeline of in‑licensing candidates.
A short summary of the press announcement, the size of the round, and the use of funds.
A short summary of the new distribution agreement and the categories covered.
A short editorial perspective from the Volo team on Canadian healthcare retail dynamics.